• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Gene . Evolutionary dynamics of Influenza A/ H3N2 virus in India from 2009 to 2023

tetano

Editor, Senior Moderator
Gene


. 2025 Oct 7:149798.
doi: 10.1016/j.gene.2025.149798. Online ahead of print. Evolutionary dynamics of Influenza A/ H3N2 virus in India from 2009 to 2023

Varsha Potdar[SUP] 1 [/SUP], Anam Dhawlarker[SUP] 2 [/SUP], Veena Vipat[SUP] 2 [/SUP], Satish Gaikwad[SUP] 2 [/SUP], Payal Kelkar[SUP] 2 [/SUP], Sheetal Jadhav[SUP] 2 [/SUP], M L Choudhary[SUP] 2 [/SUP], S Bhardwaj[SUP] 2 [/SUP], Neetu Vijay[SUP] 3 [/SUP], Nivedita Gupta[SUP] 3 [/SUP]; VRDL Laboratory network



Collaborators, Affiliations
Abstract

The influenza virus, with its propensity for rapid genetic evolution, remains a formidable global public health challenge. In particular, the H3N2 subtype of the Influenza A virus is known for its ability to continuously evolve, making it an ongoing concern for public health. To gain insights into the epidemiological dynamics of H3N2 in India, a comprehensive phylogenetic and phylogeographic analysis was conducted spanning the years 2009 to 2023. We analyzed 518 HA gene sequences from India (2009-2023), integrating 462 publicly available and 56 newly generated sequences from 19 different states in India (2018-2023). Bayesian phylogenetic and phylogeographic analyses revealed continuous H3N2 evolution in India since the mid-1990 s with an evolutionary rate of 4.95 × 10[SUP]-3[/SUP] substitutions/site/year (R[SUP]2[/SUP] = 0.95). The most recent common ancestor for Indian H3N2 sequences dated to 1995 (95 % HPD: 1992-2001), with 2023 strains predominantly belonging to clade 2a.3a.1 (characterized by I140K mutation) showing close match with WHO-recommended vaccine strains A/Darwin/6/2021.

Keywords: Epidemiology; H3N2; Hemagglutinin; India; Influenza; Molecular evolution; Phylogenetic analysis.

 
Back
Top Bottom